nexgard spectra 38 mg/8 mg comprimidos mastigáveis para cães >7,5–15 kg
afoxolaner 37.5 mg ; milbemicina oxima 7.5 mg - caninos (cães)
nexgard spectra 75 mg/15 mg comprimidos mastigáveis para cães >15–30 kg
afoxolaner 75.0 mg ; milbemicina oxima 15.0 mg - caninos (cães)
nexgard spectra 19 mg/4 mg comprimidos mastigáveis para cães >3,5–7,5 kg
afoxolaner 18.75 mg ; milbemicina oxima 3.75 mg - caninos (cães)
nexgard spectra 150 mg/30 mg comprimidos mastigáveis para cães >30–60 kg
afoxolaner 150.0 mg ; milbemicina oxima 30.0 mg - caninos (cães)
imoxat
chanelle pharmaceuticals manufacturing ltd - imidacloprido, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). o medicamento veterinário pode ser utilizado como parte de uma estratégia de tratamento para dermatite de alergia a pulga (fad). for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis). for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). o medicamento veterinário pode ser utilizado como parte de uma estratégia de tratamento para dermatite de alergia a pulga (fad).
advocate™ cães
elanco saÚde animal ltda - imidacloprid; moxidectina; - endectocidas (aÇÃo em endoparasitas e ectoparasitas) (anti-parasitÁrios)
ketesse 25 mg granulado para solução oral
menarini international operations luxembourg, s.a. - dexcetoprofeno - granulado para solução oral - 25 mg - dexcetoprofeno, trometamol 36.9 mg - dexketoprofen - n/a - duração do tratamento: curta ou média duração
ketesse 50 mg/2 ml solução injetável
menarini international operations luxembourg, s.a. - dexcetoprofeno - solução injetável - 50 mg/2 ml - dexcetoprofeno, trometamol 36.9 mg/ml - dexketoprofen - n/a - duração do tratamento: curta ou média duração
ketesse 50 mg/2 ml solução injetável
menarini international operations luxembourg, s.a. - dexcetoprofeno - solução injetável - 50 mg/2 ml - dexcetoprofeno, trometamol 36.9 mg/ml - dexketoprofen - n/a - duração do tratamento: curta ou média duração
ketesse 50 mg/2 ml solução injetável
menarini international operations luxembourg, s.a. - dexcetoprofeno - solução injetável - 50 mg/2 ml - dexcetoprofeno, trometamol 36.9 mg/ml - dexketoprofen - n/a - duração do tratamento: curta ou média duração